A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
for Small Cell Lung Cancer
Sites in Houston +5 more locations
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Sex: All·Age: 18 - 75
Code: NCT06592638·Phase 1·Recruiting·Listed Sep 2024